Vanguard Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Vanguard Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,115,277	Closed	-$6.32M	–	4551
2023 Q2	$6.32M	Hold	2,115,277	–	–	﹤0.01%	3192
2023 Q1	$7.32M	Buy	2,115,277 +28,245	+1%	+$137K	﹤0.01%	3115
2022 Q4	$8.72M	Buy	2,087,032 +73,830	+4%	+$280K	﹤0.01%	3014
2022 Q3	$8.07M	Buy	2,013,202 +55,051	+3%	+$418K	﹤0.01%	3062
2022 Q2	$22.1M	Buy	1,958,151 +953,542	+95%	+$11.4M	﹤0.01%	2590
2022 Q1	$16.3M	Buy	1,004,609 +29,729	+3%	+$762K	﹤0.01%	2887
2021 Q4	$46.2M	Buy	974,880 +23,506	+2%	+$1.41M	﹤0.01%	2395
2021 Q3	$69M	Buy	951,374 +892,026	+1,503%	+$64.5M	﹤0.01%	2188
2021 Q2	$4.98M	Buy	+59,348	New	+$3.92M	﹤0.01%	3610

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Vanguard Group's NBP Position: Q3 2023 in Review

Vanguard Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 2,115,277 shares — an estimated $6.32M sold.

Vanguard Group first reported a position in NBP in Q2 2021 and held it in 9 quarters. The position peaked at $69M in Q3 2021. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

Vanguard Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Vanguard Group sold 2,115,277 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $6.32M.
Vanguard Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 9 quarters.
Vanguard Group's NovaBridge Biosciences American Depositary Shares position peaked at $69M in Q3 2021.
47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.